Editorial
, Volume: 21( 4)International Conference on Biosimilars & Pharmaceuticals August 18-19, 2021 Berlin, Germany
- *Correspondence:
- Yulia Pavlikova
Managing Editor,
Analytical Chemistry: An Indian Journal,
UK
E-Mail: analyticalchemistry@aacseries.com
Received: May 06, 2021; Accepted: May 09, 2021; Published: May 19, 2021
Citation:Yulia Pavlikova, International Conference on Biosimilars & Pharmaceuticals August 18-19, 2021 Berlin, Germany. Anal Chem Ind J.2021;21(4):165.
Abstract
About Conference
Conference Series LLC Ltd, Scientific Event Organizer and the World Class Open Access Publisher invites all the participants from all over the world to attend “International Conference on Biosimilars & Pharmaceuticals” (Biosimilars 2021) slated on August 18-19 2021, Berlin, Germany which covers on all aspects of the pharmaceutical sciences, manufacturing, quality with strong emphasis on originality and scientific quality. This Biosimilars 2021 setting a platform for all the budding Scientists and Researchers to present their real-time work and share their views and aspects related to the theme of the Conference. The Organizing committee is gearing up for an exciting and informative Conference program including plenary Lectures, Symposia, Workshops on a variety of topics, Poster presentations and various programs for participants from all over the World.
Biosimilars 2021 conveys recent developments in Pharma drug marketing and production of Pharma drugs and contract manufacturing. A complete knowledge of a scientific discipline that described the effects of Biosimilars drug marketing and Biosimilars Pharma now explores the Scope of Biosimilars drug marketing in industry & provides detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major country markets these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the generic drug market. The wider economic environment is also considered.
Why to attend?
With members from around the world focused on learning about global trends on Biosimilars and its advances in therapeutic and diagnostic market, this is your best opportunity to reach the largest assemblage of participants from the Biosimilars community. This particular conference conduct presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2 days event. World renowned speakers, deliver speech on the most recent therapeutic and diagnostic techniques, developments in Biomarkers and Biologics. Biochemical and Biological Challenges are hallmarks of this Biosimilars 2021 conference.
